TRMK

TRMK Total Current Liabilities

$360.00MQuarterly · USD

Period ending:

TRMK FY Current LiabilitiesUSD
TRMK FY Current Liabilities1990-12-31: $3.41B1991-12-31: $3.54B1992-12-31: $3.75B1993-12-31: $4.03B1994-12-31: $4.30B1995-12-31: $4.46B1996-12-31: $4.63B1997-12-31: $4.91B1998-12-31: $5.65B1999-12-31: $6.04B2000-12-31: $5.95B2001-12-31: $6.21B2002-12-31: $5.92B2003-12-31: $6.64B2004-12-31: $7.05B2005-12-31: $7.55B2006-12-31: $8.19B2007-12-31: $7.80B2008-12-31: $8.37B2009-12-31: $8.10B2010-12-31: $8.17B2011-12-31: $8.26B2012-12-31: $8.27B2013-12-31: $10.18B2014-12-31: $10.57B2015-12-31: $10.44B2016-12-31: $11.37B2017-12-31: $12.02B2018-12-31: $11.56B2019-12-31: $11.56B2020-12-31: $14.35B2021-12-31: $15.41B2022-12-31: $14.96B2023-12-31: $16.05B2024-12-31: $15.53B2025-12-31: $3.48B$16.05B$0.00
1990-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TRMK total current liabilities history

Liabilities due within one year. The available annual fiscal periods series contains 36 observations from Dec 31, 1990 to Dec 31, 2025.

Trustmark Corp Total Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Current Liabilities (USD)
3,481,504,000
15,529,814,000
16,054,346,000
14,957,784,000
15,410,201,000
14,354,443,000
11,558,639,000
11,555,452,000
12,018,388,000
11,365,607,000
10,441,889,000
10,566,978,000
10,177,874,000
8,272,266,000
8,258,491,000
8,170,048,000
8,095,454,000
8,365,957,000
7,804,389,000
8,188,099,000
7,551,069,000
7,047,957,000
6,639,126,000
5,917,233,000
6,209,558,000
5,946,395,000
6,035,200,000
5,654,400,000
4,907,800,000
4,631,000,000
4,463,100,000
4,300,200,000
4,034,300,000
3,752,100,000
3,542,800,000
3,407,100,000

Compare total current liabilities

All TRMK financial metrics · TRMK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.